UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED SEPTEMBER 30, 2024 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 COMMISSION FILE NUMBER: 001-40254 MOVANO INC. (Exact name of registrant as specified in its charter) Delaware (Stateofincorporation) | --- | --- | |-------|-----------------------| | | ...

Exhibit 99 Movano Health Reports Q3 2024 Financial Results and Provides Business Update Highlights successful Evie Ring back-in-stock execution Updates status of EvieMED 510(k) application review Focuses on launch of EvieMED and securing B2B opportunities Conference Call at 2:00 PM PT/ 5:00 PM ET Today PLEASANTON, Calif. – November 14, 2024 – Movano Health (Nasdaq: MOVE), a pioneer in health technology, reported third quarter 2024 results and provided a business update. The Company continues to remain focus ...

Highlights successful Evie Ring back-in-stock executionUpdates status of EvieMED 510(k) application reviewFocuses on launch of EvieMED and securing B2B opportunities Conference Call at 2:00 PM PT/ 5:00 PM ET TodayPLEASANTON, Calif., Nov. 14, 2024 /PRNewswire/ -- Movano Health (Nasdaq: MOVE), a pioneer in health technology, reported third quarter 2024 results and provided a business update.The Company continues to remain focused on three key business initiatives. Successful execution of the Evie Ring direct- ...

New hardware boasts significant improvements to reduce noise and generate higher fidelity signalsPLEASANTON, Calif., Nov. 7, 2024 /PRNewswire/ -- Movano Health Inc. (Nasdaq: MOVE) announced today that it has tested its newly developed blood pressure wrist wearable as part of its November 5th and 6th hypoxia clinical trial that took place at the University of California, San Francisco. The updated device features an additional 12 mmWave antennas which together with Movano Health's custom IC delivers enhanced ...

关于财报发布与会议 - 公司Movano Health将于2024年11月14日周四股市收盘后发布2024年第三季度财报和运营结果[1] - 当天太平洋时间下午2点/美国东部时间下午5点 管理层将举办电话会议和网络直播讨论结果并提供业务更新[1] 关于会议参与方式 - 参会者可通过https://ir.movano.com或公司网站投资者板块观看网络直播[2] - 国内可拨打1 - 877 - 407 - 0989 国际可拨打1 201 - 389 - 0921参加电话会议[2] - 也可使用Call Me链接即时接入电话会议无需等待[2] - 会议结束约一小时后可在公司网站查看存档网络直播且存档两年[2] 关于公司概况 - 公司Movano Health成立于2018年 纳斯达克股票代码为MOVE 旗下产品有Evie Ring[3] - 公司正在开发一系列以医疗为目的的健康解决方案 将医疗级数据引入可穿戴设备前沿[3] - 公司设备采用现代灵活的外形 为客户和企业提供可信数据 全面捕捉个人健康数据并转化为个性化智能洞察[3] - 公司正在开发专有技术和可穿戴医疗设备解决方案 以便未来利用数据主动监测和管理医疗行业中众多患者群体的健康状况[4]

Company remains optimistic on the potential for this pioneering healthcare solutionPLEASANTON, Calif., Nov. 4, 2024 /PRNewswire/ -- Movano Health (NASDAQ: MOVE) announced today that it has submitted a complete response package to the FDA as part of the final phase of the Company's 510(k) application review of the EvieMED Ring. The Company remains optimistic on EvieMED's potential for 510(k) clearance."Our team has worked diligently to provide a thorough response to the Agency's questions," said John Mastrot ...

Company Continues to Work with Securities Regulators, Legal Advisors and Other Partners to Protect Interests of Shareholders PLEASANTON, Calif., Nov. 4, 2024 /PRNewswire/ -- Movano Health (Nasdaq: MOVE) (the "Company") provided an update on an investigation to expose apparent manipulation in trading of the Company's common shares, following the recent announcement of a shareholder approved reverse stock split.Based on its preliminary investigation, the Company believes that between the announcement of the r ...

Company Communicating with Securities Regulators, Legal Advisors and Other Partners to Protect Interests of Shareholders PLEASANTON, Calif., Oct. 31, 2024 /PRNewswire/ -- Movano Health (Nasdaq: MOVE) (the "Company") announced today that it has opened an investigation to expose apparent manipulation in trading of the Company's common shares, following the recent announcement of a shareholder approved reverse stock split."We are committed to transparency and protecting the interests of our Company and shareho ...

文章核心观点 - 公司与社交媒体名人Heidi D'Amelio建立品牌合作关系,以扩大Evie智能戒指在女性群体中的知名度 [1][2][3] - Evie是专为女性设计的智能戒指,具有多项创新功能,如适应手指尺寸变化的开放式设计、AI分析提供个性化健康洞见等 [3][4] - 公司计划通过此次合作,进一步扩大Evie的用户群,并计划在今年11月推出Android版本 [4] 公司概况 - 公司成立于2018年,是一家专注于开发医疗级可穿戴设备的公司 [5][6] - 公司正在开发自有技术和可穿戴医疗设备解决方案,以推动数据在预防性健康管理中的应用 [6] 产品信息 - Evie智能戒指具有4+天续航、60分钟快充等特点,售价269美元无需订阅 [4] - Evie提供睡眠跟踪、运动记录、目标设置等功能,帮助用户更好地了解和管理自身健康 [3]

Shares Expected to Begin Trading on Split-Adjusted Basis on October 29, 2024PLEASANTON, Calif., Oct. 25, 2024 /PRNewswire/ -- Movano Health (Nasdaq: MOVE) announced today that it will implement a 1-for-15 reverse stock split of the issued shares of its common stock (the "Reverse Stock Split"), effective at 12:01 a.m. Eastern time on October 29, 2024. The Company's common stock is expected to begin trading on a split-adjusted basis when the market opens on Tuesday, October 29, 2024, and will continue to trad ...